Literature DB >> 23381890

Development and validation of a pressure-type automated quantitative sensory testing system for point-of-care pain assessment.

Steven E Harte1, Mainak Mitra, Eric A Ichesco, Megan E Halvorson, Daniel J Clauw, Albert J Shih, Grant H Kruger.   

Abstract

Quantitative sensory testing (QST) can provide useful information about the underlying mechanisms involved in chronic pain. However, currently available devices typically employed suffer from operator-dependent effects, or are too cumbersome for routine clinical care. This paper presents the design and initial validation of a novel automated pressure-pain type QST platform, termed the multi-modal automated sensory testing (MAST) system. The MAST configuration presented consists of wireless, hand-held thumbnail pressure stimulators (with circular 10 mm² rubber tips) and graphical touch screen interface devices to manage the QST process and obtain patient feedback. Validation testing of the custom-designed force sensor showed a 1 % error for low forces increasing to 2 % error for larger loads up to 100 N (full-scale). Validation of the controller using three ramp rates (64, 248, and 496 kPa/s) and six pressures (32, 62, 124, 273, 620, and 1116 kPa) showed an overall mean error of 1.7 % for applied stimuli. Clinical evaluation revealed decreased pressure pain thresholds in chronic pain patients (98.07 ± SE 16.34 kPa) compared to pain free, healthy control subjects (259.88 ± SE 33.54 kPa, p = 0.001). The MAST system is portable and produces accurate, repeatable stimulation profiles indicating potential for point-of-care applications.

Entities:  

Mesh:

Year:  2013        PMID: 23381890     DOI: 10.1007/s11517-013-1033-x

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  54 in total

1.  Dolorimetry performed at 3 paired tender points highly predicts overall tenderness.

Authors:  F Petzke; A Khine; D Williams; K Groner; D J Clauw; R H Gracely
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

2.  The effects of experimenter gender on pain report in male and female subjects.

Authors:  Fredric M Levine; Laura Lee De Simone
Journal:  Pain       Date:  1991-01       Impact factor: 6.961

Review 3.  Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states.

Authors:  Per Hansson; Miroslav Backonja; Didier Bouhassira
Journal:  Pain       Date:  2007-04-23       Impact factor: 6.961

Review 4.  Can we predict persistent postoperative pain by testing preoperative experimental pain?

Authors:  Michal Granot
Journal:  Curr Opin Anaesthesiol       Date:  2009-06       Impact factor: 2.706

Review 5.  Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states.

Authors:  David Yarnitsky
Journal:  Curr Opin Anaesthesiol       Date:  2010-10       Impact factor: 2.706

6.  The reproducibility of cephalic pain pressure thresholds in control subjects and headache patients.

Authors:  T Sand; J A Zwart; G Helde; G Bovim
Journal:  Cephalalgia       Date:  1997-11       Impact factor: 6.292

7.  Factor analysis of responses to thermal, electrical, and mechanical painful stimuli supports the importance of multi-modal pain assessment.

Authors:  Alban Y Neziri; Michele Curatolo; Eveline Nüesch; Pasquale Scaramozzino; Ole K Andersen; Lars Arendt-Nielsen; Peter Jüni
Journal:  Pain       Date:  2011-03-10       Impact factor: 6.961

8.  Interrater reliability of algometry in measuring pressure pain thresholds in healthy humans, using multiple raters.

Authors:  Linda S Chesterton; Julius Sim; Christine C Wright; Nadine E Foster
Journal:  Clin J Pain       Date:  2007 Nov-Dec       Impact factor: 3.442

9.  Enhanced presurgical pain temporal summation response predicts post-thoracotomy pain intensity during the acute postoperative phase.

Authors:  Irit Weissman-Fogel; Yelena Granovsky; Yonathan Crispel; Alon Ben-Nun; Lael Anson Best; David Yarnitsky; Michal Granot
Journal:  J Pain       Date:  2009-04-23       Impact factor: 5.820

10.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Authors:  Richard H Gracely; Frank Petzke; Julie M Wolf; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2002-05
View more
  20 in total

Review 1.  Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network.

Authors:  J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis
Journal:  Nat Rev Urol       Date:  2019-03       Impact factor: 14.432

2.  Resting Functional Connectivity of the Periaqueductal Gray Is Associated With Normal Inhibition and Pathological Facilitation in Conditioned Pain Modulation.

Authors:  Daniel E Harper; Eric Ichesco; Andrew Schrepf; Johnson P Hampson; Daniel J Clauw; Tobias Schmidt-Wilcke; Richard E Harris; Steven E Harte
Journal:  J Pain       Date:  2018-01-31       Impact factor: 5.820

3.  NIR spectroscopic determination of urine components in spot urine: preliminary investigation towards optical point-of-care test.

Authors:  Ikuto Suzuki; Mitsuhiro Ogawa; Kimihiro Seino; Masamichi Nogawa; Hisashi Naito; Ken-Ichi Yamakoshi; Shinobu Tanaka
Journal:  Med Biol Eng Comput       Date:  2019-11-19       Impact factor: 2.602

4.  Pressure Pain Sensitivity in Patients With Suspected Opioid-Induced Hyperalgesia.

Authors:  Ronald A Wasserman; Afton L Hassett; Steven E Harte; Jenna Goesling; Herbert L Malinoff; Daniel W Berland; Jennifer Zollars; Stephanie E Moser; Chad M Brummett
Journal:  Reg Anesth Pain Med       Date:  2015 Nov-Dec       Impact factor: 6.288

5.  Pressure sensitivity and phenotypic changes in patients with suspected opioid-induced hyperalgesia being withdrawn from full mu agonists.

Authors:  Ronald A Wasserman; Afton L Hassett; Steven E Harte; Jenna Goesling; Herbert L Malinoff; Daniel W Berland; Jennifer Zollars; Stephanie E Moser; Chad M Brummett
Journal:  J Nat Sci       Date:  2017-02

6.  The Multidisciplinary Approach to The Study of Chronic Pelvic Pain (MAPP) Research Network*: Design and implementation of the Symptom Patterns Study (SPS).

Authors:  J Quentin Clemens; Jason J Kutch; Emeran A Mayer; Bruce D Naliboff; Larissa V Rodriguez; David J Klumpp; Anthony J Schaeffer; Karl J Kreder; Daniel J Clauw; Steven E Harte; Andrew D Schrepf; David A Williams; Gerald L Andriole; H Henry Lai; Dedra Buchwald; M Scott Lucia; Adrie van Bokhoven; Sean Mackey; Robert M Moldwin; Michel A Pontari; Alisa J Stephens-Shields; Chris Mullins; J Richard Landis
Journal:  Neurourol Urodyn       Date:  2020-06-23       Impact factor: 2.696

7.  Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study.

Authors:  Andrew Schrepf; Catherine S Bradley; Michael O'Donnell; Yi Luo; Steven E Harte; Karl Kreder; Susan Lutgendorf
Journal:  Brain Behav Immun       Date:  2015-03-11       Impact factor: 7.217

8.  Association Between the 2011 Fibromyalgia Survey Criteria and Multisite Pain Sensitivity in Knee Osteoarthritis.

Authors:  Stephen J Neville; Andrew D Clauw; Stephanie E Moser; Andrew G Urquhart; Daniel J Clauw; Chad M Brummett; Steven E Harte
Journal:  Clin J Pain       Date:  2018-10       Impact factor: 3.442

9.  The LURN Research Network Neuroimaging and Sensory Testing (NIST) Study: Design, protocols, and operations.

Authors:  H Henry Lai; Bruce Naliboff; Alice B Liu; Cindy L Amundsen; Joshua S Shimony; Vincent A Magnotta; Joseph J Shaffer; Robin L Gilliam; Jonathan B Wiseman; Margaret E Helmuth; Victor P Andreev; Ziya Kirkali; Steven E Harte
Journal:  Contemp Clin Trials       Date:  2018-09-21       Impact factor: 2.226

10.  Phenotypic Features of Central Sensitization.

Authors:  David A Williams
Journal:  J Appl Biobehav Res       Date:  2018-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.